INTERNATIONAL PATENT: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FILES APPLICATION FOR "PANCREATIC CANCER IMMUNOTHERAPY USING CATIONIC LIPID AND POLYMER NANOCARRIERS FOR CO-DELIVERY OF KRAS NEOANTIGENS AND STING AND/OR OTHER IMMUNOMODULATORS TO BOOST THE CANCER IMMUNITY CYCLE AND TREAT LIVER METASTASIS"

GENEVA, April 21 -- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1111 Franklin StreetTwelfth FloorOakland, California 94607-5200) filed a patent application (PCT/US2024/050819) for "PANCREATIC CANCER IMMUNOTHERAPY USING CATIONIC LIPID AND POLYMER NANOCARRIERS FOR CO-DELIVERY OF KRAS NEOANTIGENS AND STING AND/OR OTHER IMMUNOMODULATORS TO BOOST THE CANCER IMMUNITY CYCLE AND TREAT LIVER METASTASIS" on Oct 10, 2024. With publication no. WO/2025/080869, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NEL, Andre E. (c/o UCLA Te...